TP53 and adenocarcinoma: We found an excess of TP53 mutations in the mucinous endocervical histotype (54%), however no other study to date addressed the issue of gene mutation distribution across the different subtypes of adenocarcinoma such as endocervical, endometrioid, intestinal, and mixed adenocarcinoma.